Menno Kiel

Menno Kiel is an experienced consultant currently working at GLG since September 2023. Previously, Menno served as the Global Medical Director & Medical Lead in Hemato-Oncology at Roche from July 2020 to July 2023, overseeing compassionate use programs for bispecific monoclonal antibodies. Prior roles include Global Study Responsible Physician at Actelion, Regional Medical Advisor for Hemato-Oncology at Janssen, and Country Medical Advisor for Women’s Cancer at AstraZeneca. Menno has also held academic positions, such as Program Director & Medical Lecturer at Hogeschool Rotterdam, and has contributed to clinical trials and health economics research. Menno holds a Doctor of Medicine (MD) from the University of Amsterdam, a Master of Science in Health Economics, Policy & Law from Erasmus University Rotterdam, and a mini-MBA from Vlerick Business School.